TGTX
Tg Therapeutics, Inc.Company with tickers: TGTX
CIK
1001316
CUSIP
88322Q108
Shares Outstanding
153,083,580
Website
https://www.tgtherapeutics.com
Investor Relations
https://www.tgtherapeutics.com/investors-media/
13F Activity (30d)
30 filings
8 filers
Price
$53.22
Market Cap
$8.15B
P/E Ratio
19.21
EPS (Diluted)
$2.77
52W High
$54.07
52W Low
$25.28
Daily candlestick prices with configurable technical indicators (moving averages, Bollinger Bands, RSI, MACD) and event bullets for 10-K, 10-Q, Form 4 and earnings dates. Price data syncs automatically from Yahoo Finance.
Latest guidance
from the 8-K filed May 6, 2026
| Metric | Period | Guided | Basis | Actual |
|---|---|---|---|---|
| total global revenue | full year 2026 | $925M | — | — |
| BRIUMVI U.S. net product revenue | second quarter 2026 | $220M | — | — |
9 Up Days
Indicators
Price
Panels
Event markers
Price & Indicators
Drag to pan · scroll to zoomPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TGTX | +10.8% | +33.9% | +71.3% | +40.3% | +78.5% |
| SPY | +1.8% | +1.6% | +9.6% | -0.8% | +10.0% |
| vs SPY | +9.0% | +32.3% | +61.7% | +41.1% | +68.5% |
Close
$53.22
Open
$52.23
Day Range
$51.95 — $54.07
52W High
$54.07
52W Low
$25.28
Avg Vol (30d)
2.1M
Short Interest
28.2M · 21.6d
Short Vol % (latest)
47%
Last Earnings
2026-05-06
Latest Filing
Data Range
2020-01-02 — 2026-06-18